High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma

Published:2020-01-13 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Luo Liuping¹,Chen Lihong²,Ke Kun¹,Zhao Bixing²,Wang Lili³,Zhang Cuilin²,Wang Fei²,Liao Naishun²,Zheng Xiaoyuan²,Liu Xiaolong²,Wang Yingchao²,Liu Jingfeng²

Affiliation:

1. he First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China

2. The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian 350025, P.R. China

3. Department of Diagnostic Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The XPA Protein—Life under Precise Control;Cells;2022-11-22

2. Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer;Frontiers in Oncology;2022-11-08

3. Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning;Frontiers in Genetics;2022-09-06

4. Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma;Bosnian Journal of Basic Medical Sciences;2021-04-12

5. Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis;Genes;2020-09-06